TXNIP and atrial fibrillation: Furthermore, Zbtb16-KD or Txnip-KD could inhibit the occurrence of DADs and reduce the incidence and duration of AF in ACh-CaCl2-induced AF model (Fig. 7A–E) with trends of atrial interstitial fibrosis area decreasing (Fig. S5B).